Wilson Sonsini Goodrich & Rosati’s 2019 Technology and Life Sciences IPO Report presents analysis related to the closing of 87 initial public offerings completed by U.S.-based technology and life sciences issuers between January 1 and December 31, 2019. The report includes IPO filing, pricing, and value statistics for both sectors; governance and board of director details; ownership and deal structure factors; and defensive measure data points.

2019 was another vibrant year for tech and life sciences IPOs, with just a slight decline from 2018 despite the U.S. government shutdown and market volatility that slowed IPO activity in early 2019. Comparing this year’s report with the firm’s 2018 year-end edition, the number of IPOs in 2019 fell only six short of the 93 tech and life sciences IPOs in 2018.